Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

404

Not found

This newslink doesn't exist or it was removed.

Go to Homempage.

Sugerencias de la Hemeroteca

Pfizer CEO reveals 2030 growth plan as company faces up to $18 billion revenue hit from generics

CNBC USA Health November 02, 2022

thumbnailPfizer CEO Albert Bourla talks during a press conference with European Commission President after a visit to oversee the production of the Pfizer-BioNtech Covid-19 vaccine at the factory of US pharmaceutical company Pfizer, in Puurs, on April 23, 2021.John Thys AFP Getty Images... + más

Pfizer raises 2022 earnings guidance, beats third-quarter expectations | CNBC

Pfizer climbs on strong Q3 results, raised outlook | MarketWatch


Pfizer rejects Moderna claim it copied Covid vaccine, accuses rival of rewriting history

CNBC USA Health December 06, 2022

thumbnailVials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021.Dado Ruvic Reuters has rejected allegations made by rival that its Covid-19 vaccine is a copy, accusing the Boston biotech company of... + más

Moderna sues Pfizer over patents behind COVID-19 vaccine | The Advocate

Moderna is suing Pfizer over its coronavirus vaccine | The Verge


Pfizer's stock on pace for biggest drop in 15 years as profit and revenue guidance falls short of expectations

MarketWatch USA Business December 13, 2023

thumbnailAs it wrestles with reduced COVID sales expectations and acquires cancer-drug maker Seagen, Pfizer is expecting 2024 revenue to range from $58.5 billion to $61.5 billion, below the $62.6 billion FactSet consensus. The company expects adjusted earnings per share to range from... + más

NFL Playoff Scenarios | ABC News

Le Krewe du Roi celebrates the state at 58th annual Mardi Gras Ball | The Advocate


FDA Authorizes Bivalent Pfizer Covid Vaccine As Booster Dose For Select Children Under 5

RTTNews USA Health March 15, 2023

thumbnailThe U.S. Food and Drug Administration has authorized bivalent Pfizer-BioNTech covid-19 vaccine as booster dose for certain children 6 months through 4 years of age.In a statement, the regulator said it has amended the emergency use authorization or EUA of the Pfizer-BioNTech... + más

FDA Authorizes Bivalent Pfizer Covid Vaccine As Booster Dose For Select Children Under 5 | RTTNews

Amid pathetic uptake, FDA green lights confusing COVID vaccine update for kids | Ars Technica


FDA Authorizes Bivalent Pfizer Covid Vaccine As Booster Dose For Select Children Under 5

RTTNews USA Health March 15, 2023

thumbnailThe U.S. Food and Drug Administration has authorized bivalent Pfizer-BioNTech covid-19 vaccine as booster dose for certain children 6 months through 4 years of age.In a statement, the regulator said it has amended the emergency use authorization or EUA of the Pfizer-BioNTech... + más

FDA Authorizes Bivalent Pfizer Covid Vaccine As Booster Dose For Select Children Under 5 | RTTNews

Amid pathetic uptake, FDA green lights confusing COVID vaccine update for kids | Ars Technica



About iurex | Privacy Policy | Disclaimer |